The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,649.00
Bid: 0.00
Ask: 4,818.00
Change: 0.00 (0.00%)
Spread: 175.00 (3.769%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4,649.00
CRDA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

16 Dec 2019 07:00

RNS Number : 8814W
Croda International PLC
16 December 2019
 

16 December 2019

 

Croda International Plc

 

Appointment of Non-Executive Director - Board succession planning

 

The Board of Croda International Plc is pleased to announce the appointment of John Ramsay as a Non-Executive Director with effect from 1 January 2020.

 

John, a Chartered Accountant, served as Chief Financial Officer of Syngenta AG from 2007 to 2016 and was also Interim Chief Executive Officer from October 2015 to June 2016. Prior to this, John served as Group Financial Controller of Syngenta from 2000 to 2007 and as the Finance Head of Asia Pacific for Zeneca Agrochemicals from 1993 to 1999. Earlier in his career he was a Financial Controller of ICI Malaysia and regional controller for Latin America. Before joining ICI in 1984, he worked in audit and tax at KPMG. John is a member of the Supervisory Board at Koninklijke DSM N.V. and a Non-Executive Director of G4S plc and RHI Magnesita N.V. He is Audit Committee Chair on all three boards.

 

On joining the Board, John will be appointed to the Audit, Nomination and Remuneration Committees.

 

Alan Ferguson will retire from the Board on 23 April 2020 following the AGM after nine years as a Non-Executive Director. John Ramsay will take over as Chair of the Audit Committee and Helena Ganczakowski will take on the role as Senior Independent Director. Helena has been on the Board since February 2014 and is the Chair of the Remuneration Committee.

 

Anita Frew, Chair of Croda International Plc, commented:

 

"John brings with him a wealth of financial, international and sector experience. John has a Life Sciences background with ICI, AstraZeneca and Syngenta and brings a deep emerging market experience from his 10 years living and working in Asia and from his work in Latin America. We are delighted to welcome him to the Board. John's appointment in January 2020 will allow for a period of hand over before he takes the role as Audit Committee Chair in April 2020. His strong background as an Audit Committee Chair will be of enormous benefit to the Croda Board and complement and enhance the significant expertise we already have on the Board.

 

"I am delighted that Helena Ganczakowski is stepping up to become Senior Independent Director. She has extensive Board experience and has demonstrated strong leadership of the Remuneration Committee.

 

"Alan Ferguson has made an outstanding contribution to the Board, both as Audit Committee Chair and Senior Non-Executive Director, and, on behalf of the Board and his colleagues, we thank him for all his advice and support and wish him all the best for the future."

 

There are no further matters to be disclosed under LR9.6.13R of the Listing Rules of the UK Listing Authority.

 

 

 

Enquiries:

 

Jez Maiden, Group Finance Director, Croda International Plc

investor.relations@croda.com

+44 (0)1405 860551

 

Charlie Armitstead, Teneo

charles.armitstead@teneo.com 

+44 (0)7703 330 269

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAMMMMZKFNGLZM
Date   Source Headline
25th Apr 202410:01 amRNSResult of AGM
24th Apr 20247:00 amRNSFirst quarter 2024 sales update
11th Apr 20242:11 pmRNSDirector/PDMR Shareholding
8th Apr 202410:54 amRNSDirector/PDMR Shareholding
8th Apr 202410:23 amRNSDirector/PDMR Shareholding
28th Mar 20249:17 amRNSDirector/PDMR Shareholding
26th Mar 20244:19 pmRNSDirector/PDMR Shareholding
26th Mar 20244:10 pmRNSDirector/PDMR Shareholding
26th Mar 20244:09 pmRNSDirector/PDMR Shareholding
26th Mar 20244:09 pmRNSDirector/PDMR Shareholding
26th Mar 20244:07 pmRNSDirector/PDMR Shareholding
26th Mar 20244:06 pmRNSDirector/PDMR Shareholding
26th Mar 20244:04 pmRNSDirector/PDMR Shareholding
15th Mar 20249:32 amRNSAnnual Financial Report
12th Mar 20242:49 pmRNSDirector/PDMR Shareholding
7th Mar 20243:03 pmRNSDirector/PDMR Shareholding
27th Feb 20247:00 amRNSResults for the year ended 31 December 2023
13th Feb 20243:35 pmRNSDirector/PDMR Shareholding
9th Feb 20243:28 pmRNSHolding(s) in Company
18th Jan 20241:33 pmRNSHolding(s) in Company
11th Jan 20243:17 pmRNSDirector/PDMR Shareholding
18th Dec 20237:00 amRNSDirectorate Change
12th Dec 20233:08 pmRNSDirector/PDMR Shareholding
11th Dec 202311:39 amRNSDirector Declaration
29th Nov 20234:54 pmRNSHolding(s) in Company
28th Nov 20239:35 amRNSDirector/PDMR Shareholding
24th Nov 202311:33 amRNSHolding(s) in Company
14th Nov 20239:40 amRNSDirector/PDMR Shareholding
19th Oct 202311:19 amRNSHolding(s) in Company
19th Oct 202310:34 amRNSDirector/PDMR Shareholding
12th Oct 202311:46 amRNSDirector/PDMR Shareholding
9th Oct 20237:00 amRNSThird Quarter Trading Update
6th Oct 20234:12 pmRNSDirector/PDMR Shareholding
5th Oct 20238:53 amRNSHolding(s) in Company
3rd Oct 20234:03 pmRNSDirector/PDMR Shareholding
27th Sep 20235:17 pmRNSDirector/PDMR Shareholding
26th Sep 202311:38 amRNSDirector/PDMR Shareholding
22nd Sep 20237:00 amRNSDirectorate Change
15th Sep 202311:51 amRNSDirector/PDMR Shareholding
12th Sep 20234:01 pmRNSDirector/PDMR Shareholding
12th Sep 20238:56 amRNSDirector/PDMR Shareholding
11th Aug 20232:26 pmRNSDirector/PDMR Shareholding
1st Aug 20237:13 amRNSDirector Declaration
25th Jul 20237:00 amRNSResults for the six months ended 30 June 2023
11th Jul 20232:57 pmRNSDirector/PDMR Shareholding
4th Jul 20238:02 amRNSCroda completes acquisition of Solus Biotech
26th Jun 202310:46 amRNSHolding(s) in Company
13th Jun 20233:55 pmRNSDirector/PDMR Shareholding
12th Jun 20232:06 pmRNSDirector/PDMR Shareholding
9th Jun 20237:00 amRNSTrading update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.